• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与凸面脑膜瘤相比,主要为世界卫生组织分级 1 级的颅底脑膜瘤的免疫细胞基因表达图谱具有独特性。

Landscape of immune cell gene expression is unique in predominantly WHO grade 1 skull base meningiomas when compared to convexity.

机构信息

Division of Neurosurgery, Department of Surgery, St. Michael's Hospital, Toronto, ON, Canada.

出版信息

Sci Rep. 2020 Jun 3;10(1):9065. doi: 10.1038/s41598-020-65365-7.

DOI:10.1038/s41598-020-65365-7
PMID:32493984
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7270140/
Abstract

Modulation of tumor microenvironment is an emerging frontier for new therapeutics. However in meningiomas, the most frequent adult brain tumor, the correlation of microenvironment with tumor phenotype is scarcely studied. We applied a variety of systems biology approaches to bulk tumor transcriptomics to explore the immune environments of both skull base and convexity (hemispheric) meningiomas. We hypothesized that the more benign biology of skull base meningiomas parallels the relative composition and activity of immune cells that oppose tumor growth and/or survival. We firstly applied gene co-expression networks to tumor bulk transcriptomics from 107 meningiomas (derived from 3 independent studies) and found immune processes to be the sole biological mechanism correlated with anatomical location while correcting for tumour grade. We then derived tumor immune cell fractions from bulk transcriptomics data and examined the immune cell-cytokine interactions using a network-based approach. We demonstrate that oncolytic Gamma-Delta T cells dominate skull base meningiomas while mast cells and neutrophils, known to play a role in oncogenesis, show greater activity in convexity tumors. Our results are the first to suggest the importance of tumor microenvironment in meningioma biology in the context of anatomic location and immune landscape. These findings may help better inform surgical decision making and yield location-specific therapies through modulation of immune microenvironment.

摘要

肿瘤微环境的调控是新疗法的一个新兴前沿。然而,在脑膜瘤中,最常见的成人脑肿瘤,微环境与肿瘤表型的相关性几乎没有研究。我们应用了各种系统生物学方法对脑膜瘤的大量肿瘤转录组进行研究,以探索颅底和大脑半球脑膜瘤的免疫环境。我们假设颅底脑膜瘤的生物学特性更为良性,这与对抗肿瘤生长和/或存活的免疫细胞的相对组成和活性有关。我们首先将基因共表达网络应用于来自 107 例脑膜瘤(来自 3 个独立研究)的肿瘤大量转录组学,并发现免疫过程是唯一与解剖位置相关的生物学机制,同时纠正了肿瘤分级。然后,我们从大量转录组学数据中提取肿瘤免疫细胞分数,并使用基于网络的方法研究免疫细胞-细胞因子相互作用。我们证明,溶瘤性γ-δ T 细胞在颅底脑膜瘤中占主导地位,而肥大细胞和中性粒细胞,已知在肿瘤发生中起作用,在大脑半球肿瘤中表现出更大的活性。我们的研究结果首次表明,在解剖位置和免疫图谱的背景下,肿瘤微环境在脑膜瘤生物学中的重要性。这些发现可能有助于更好地为手术决策提供信息,并通过调节免疫微环境产生特定于位置的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0712/7270140/3f53f0901fe6/41598_2020_65365_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0712/7270140/29ddf9aecb5c/41598_2020_65365_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0712/7270140/c1c6125a7373/41598_2020_65365_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0712/7270140/3f53f0901fe6/41598_2020_65365_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0712/7270140/29ddf9aecb5c/41598_2020_65365_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0712/7270140/c1c6125a7373/41598_2020_65365_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0712/7270140/3f53f0901fe6/41598_2020_65365_Fig3_HTML.jpg

相似文献

1
Landscape of immune cell gene expression is unique in predominantly WHO grade 1 skull base meningiomas when compared to convexity.与凸面脑膜瘤相比,主要为世界卫生组织分级 1 级的颅底脑膜瘤的免疫细胞基因表达图谱具有独特性。
Sci Rep. 2020 Jun 3;10(1):9065. doi: 10.1038/s41598-020-65365-7.
2
Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas.非 NF2 突变对颅底脑膜瘤的抑制性免疫检查点和肿瘤发病机制有重要影响。
J Neurooncol. 2019 Aug;144(1):11-20. doi: 10.1007/s11060-019-03198-9. Epub 2019 Jun 8.
3
WHO grade, proliferation index, and progesterone receptor expression are different according to the location of meningioma.世界卫生组织分级、增殖指数和孕激素受体表达因脑膜瘤位置而异。
Acta Neurochir (Wien). 2019 Dec;161(12):2553-2561. doi: 10.1007/s00701-019-04084-z. Epub 2019 Oct 21.
4
Proteins involved in regulating bone invasion in skull base meningiomas.参与颅底脑膜瘤骨侵袭调节的蛋白质。
Acta Neurochir (Wien). 2013 Mar;155(3):421-7. doi: 10.1007/s00701-012-1577-9. Epub 2012 Dec 13.
5
Adoptive transfer of genetically modified Wilms' tumor 1-specific T cells in a novel malignant skull base meningioma model.在一种新的恶性颅底脑膜瘤模型中过继转移基因修饰的 Wilms' 肿瘤 1 特异性 T 细胞。
Neuro Oncol. 2013 Jun;15(6):747-58. doi: 10.1093/neuonc/not007. Epub 2013 Mar 3.
6
Immunological and vascular characteristics in cavernous sinus meningioma.海绵窦脑膜瘤的免疫和血管特征。
J Clin Neurosci. 2019 Sep;67:198-203. doi: 10.1016/j.jocn.2019.06.003. Epub 2019 Jun 15.
7
Differential Tumor Progression Patterns in Skull Base Versus Non-Skull Base Meningiomas: A Critical Analysis from a Long-Term Follow-Up Study and Review of Literature.颅底与非颅底脑膜瘤的不同肿瘤进展模式:来自长期随访研究及文献综述的批判性分析
World Neurosurg. 2018 Apr;112:e74-e83. doi: 10.1016/j.wneu.2017.12.035. Epub 2017 Dec 16.
8
Slower growth of skull base meningiomas compared with non-skull base meningiomas based on volumetric and biological studies.基于体积和生物学研究,颅底脑膜瘤的生长速度较非颅底脑膜瘤慢。
J Neurosurg. 2012 Mar;116(3):574-80. doi: 10.3171/2011.11.JNS11999. Epub 2011 Dec 16.
9
Malignant potential of skull base versus non-skull base meningiomas: clinical series of 1,663 cases.颅底与非颅底脑膜瘤的恶性潜能:1663 例临床系列。
Acta Neurochir (Wien). 2013 Mar;155(3):407-13. doi: 10.1007/s00701-012-1611-y. Epub 2013 Jan 15.
10
A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas.非颅底和颅底脑膜瘤患者复发时世界卫生组织肿瘤分级的比较。
J Neurosurg. 2010 May;112(5):925-33. doi: 10.3171/2009.9.JNS09617.

引用本文的文献

1
Skull-meninges-brain connectivity and extra-axial brain tumours.颅骨-脑膜-脑连接与脑外肿瘤
Brain Commun. 2025 Aug 21;7(5):fcaf311. doi: 10.1093/braincomms/fcaf311. eCollection 2025.
2
The Molecular and Immunological Landscape of Meningiomas.脑膜瘤的分子与免疫学特征
Int J Mol Sci. 2024 Sep 5;25(17):9631. doi: 10.3390/ijms25179631.
3
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients.脑膜瘤:脑膜瘤国际联合会关于临床医生、研究人员和患者的科学进展和治疗模式的共识综述。
Neuro Oncol. 2024 Oct 3;26(10):1742-1780. doi: 10.1093/neuonc/noae082.
4
Immune Profiling of Meningiomas.脑膜瘤的免疫分析。
Adv Exp Med Biol. 2023;1416:189-198. doi: 10.1007/978-3-031-29750-2_14.
5
The Tumor Immune Microenvironment in Primary CNS Neoplasms: A Review of Current Knowledge and Therapeutic Approaches.原发性中枢神经系统肿瘤的肿瘤免疫微环境:当前知识和治疗方法的综述。
Int J Mol Sci. 2023 Jan 19;24(3):2020. doi: 10.3390/ijms24032020.
6
The Long and Winding Road: An Overview of the Immunological Landscape of Intracranial Meningiomas.漫长而曲折的道路:颅内脑膜瘤免疫格局概述
Cancers (Basel). 2022 Jul 26;14(15):3639. doi: 10.3390/cancers14153639.
7
Residual Tumor Volume and Tumor Progression after Subtotal Resection and Observation of WHO Grade I Skull Base Meningiomas.WHO I级颅底脑膜瘤次全切除及观察后的残余肿瘤体积与肿瘤进展
J Neurol Surg B Skull Base. 2021 Sep 9;83(Suppl 2):e530-e536. doi: 10.1055/s-0041-1733974. eCollection 2022 Jun.
8
Synthesizing Molecular and Immune Characteristics to Move Beyond WHO Grade in Meningiomas: A Focused Review.综合分子和免疫特征以超越脑膜瘤的世界卫生组织分级:聚焦综述
Front Oncol. 2022 May 31;12:892004. doi: 10.3389/fonc.2022.892004. eCollection 2022.
9
Integrated computational analyses reveal novel insights into the stromal microenvironment of SHH-subtype medulloblastoma.综合计算分析揭示了 SHH 亚型髓母细胞瘤基质微环境的新见解。
Sci Rep. 2021 Oct 19;11(1):20694. doi: 10.1038/s41598-021-00244-3.
10
The spatial phenotype of genotypically distinct meningiomas demonstrate potential implications of the embryology of the meninges.不同基因型脑膜瘤的空间表型显示了脑膜胚胎学的潜在意义。
Oncogene. 2021 Feb;40(5):875-884. doi: 10.1038/s41388-020-01568-6. Epub 2020 Dec 1.